K. Murase

发表

Usefulness of Real-Time 4D Ultrasonography during Radiofrequency Ablation in a Case of Hepatocellular Carcinoma

N. Hotta, Seigo Yamada, K. Murase, 2011, Case Reports in Gastroenterology.

Original contributionAmino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon

K. Murase, M. Ishigami, K. Takagi, 2002 .

Prevalence of diabetes mellitus in Japanese patients infected chronically with hepatitis C virus

K. Murase, T. Ishikawa, K. Yoshioka, 2003, Journal of Gastroenterology.

In vitro synthesis of antibody to hepatitis B virus antigen by circulating lymphocytes from chronic HBsAg carriers and patients with acute hepatitis B

K. Murase, K. Yoshioka, S. Kakumu, 1986, Gastroenterologia Japonica.

Proliferation and immunoglobulin synthesis of peripheral blood mononuclear cells from patients with chronic liver disease stimulated by staphylococcus aureus cowan 1 and interleukin 2

K. Murase, S. Kakumu, A. Fuji, 1987, Gastroenterologia Japonica.

Amino acid substitutions in the nonstructural region 5A of hepatitis C virus genotypes 2a and 2b and its relation to viral load and response to interferon

K. Murase, M. Ishigami, K. Takagi, 2002, American Journal of Gastroenterology.

Interferon‐γ production by peripheral blood mononuclear cells of patients with chronic liver disease

K. Murase, S. Kakumu, A. Fuji, 1987 .

Randomized controlled trial of twice-a-day administration of natural interferon β for chronic hepatitis C

K. Murase, T. Ishikawa, K. Yoshioka, 2000 .

Randomized controlled trial of lymphoblastoid interferon α for chronic hepatitis C (comparison of 9-MU and 6-MU doses)

K. Murase, K. Yoshioka, S. Kakumu, 1999, American Journal of Gastroenterology.

Autoantibodies against liver cell membrane antigens detected by enzyme-linked immunosorbent assay in acute and chronic liver disease.

K. Murase, S. Kakumu, A. Fuji, 1987, Clinical immunology and immunopathology.

Enhancement of antibody production to hepatitis B surface antigen by anti-idiotypic antibody.

K. Murase, K. Yoshioka, S. Kakumu, 1986, Gut.

Pilot study of recombinant human interleukin 2 for chronic type B hepatitis

K. Murase, K. Yoshioka, S. Kakumu, 1988, Hepatology.

Biochemical response to interferon therapy correlates with interferon sensitivity‐determining region in hepatitis C virus genotype 1b infection

K. Murase, M. Mizokami, K. Yoshioka, 2001, Journal of viral hepatitis.

Randomized controlled trial of lymphoblastoid interferon alpha for chronic hepatitis C (comparison of 9-MU and 6-MU doses). IFN Treatment Group of Affiliated Hospitals of the Third Department of Internal Medicine at Nagoya University School of Medicine.

K. Murase, K. Yoshioka, S. Kakumu, 1999, The American journal of gastroenterology.

Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.

K. Murase, S. Kakumu, A. Fuji, 1987, Clinical and experimental immunology.

Interferon-gamma production by peripheral blood mononuclear cells of patients with chronic liver disease.

K. Murase, S. Kakumu, A. Fuji, 1987, Hepatology.

Pilot study of recombinant human alpha-interferon for chronic non-A, non-B hepatitis.

K. Murase, K. Yoshioka, S. Kakumu, 1989, The American journal of gastroenterology.